News

Clinitech Laboratory Limited informed the BSE Limited that the regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 is not applicable to the company for the quarter ended September 30, 2026, as all shares are held in demat form and no requests for rematerialisation were received, according to a certificate from Registrar and Transfer Agent Bigshare Services Pvt. Ltd.

Clinitech Laboratory Limited will close its trading window for insiders from Thursday, October 1, 2026, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the consideration and approval of the unaudited standalone and consolidated financial results for the half year ending September 30, 2026, with the window reopening 48 hours after the results are declared.

Clinitech Laboratory Limited informed the BSE Limited, National Securities Depository Limited, and Central Depository Services (India) Limited that the register of members and share transfer books will be closed from Friday, September 18, 2025, to Thursday, September 24, 2026, for the company’s 16th Annual General Meeting scheduled to be held on Thursday, September 24, 2026, at 11:30 A.M. (IST).

Clinitech Laboratory Limited will hold a board meeting on August 17, 2026, via video conference to consider the appointment of a retiring director, approve the company’s FY 2025-26 board’s report, finalize the notice for the 16th Annual General Meeting, and appoint Mr. Deep Shukla, Practising Company Secretary, as the scrutinizer for the voting process, according to a regulatory filing.

Clinitech Laboratory will hold a meeting of the Board of Directors of the Company on 28 May 2026.